Karyopharm Therapeutics Inc. (KPTI), a company focused on novel cancer therapies, said on Thursday that it has appointed Lori Macomber as Chief Financial Officer with effect from January 3.
Macomber, with over 20 years of diversified experience, most recently served as CFO of Legend Biotech Corporation. Previously, she held leadership roles of increasing responsibility at Ametek PDS, Cello Health, Eli Lilly and Company, and Pfizer.
For comments and feedback: editorial@rttnews.com